MoneyWorks4Me

Godavari Drugs - Quaterly Results

12 Feb 2025 Evaluate
The sales is pegged at Rs. 295.52 millions for the December 2024 quarter. The mentioned figure indicates a decline of about -31.45% as against Rs. 431.10 millions during the year-ago period.The Company to register a -37.23%  fall in the net profit for the quarter ended December 2024.The Operating Profit of the company witnessed a decrease to 26.75 millions from 35.70 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 295.52 431.10 -31.45 878.48 1180.71 -25.60 1567.12 1596.25 -1.82
Other Income 0.98 0.50 96.00 8.72 5.05 72.67 6.18 6.55 -5.65
PBIDT 26.75 35.70 -25.07 95.87 93.37 2.68 139.22 105.76 31.64
Interest 11.10 12.75 -12.94 36.25 36.83 -1.57 49.15 39.27 25.16
PBDT 15.65 22.37 -30.04 59.62 55.96 6.54 89.17 68.79 29.63
Depreciation 6.44 4.95 30.10 17.76 14.63 21.39 19.95 19.44 2.62
PBT 9.21 17.42 -47.13 41.86 41.33 1.28 69.22 49.35 40.26
TAX 1.54 5.20 -70.38 6.99 12.46 -43.90 13.73 11.49 19.50
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 7.67 12.22 -37.23 34.87 28.87 20.78 55.49 37.86 46.57
Equity 75.30 75.30 0.00 75.30 75.30 0.00 75.31 75.31 0.00
PBIDTM(%) 9.05 8.28 9.31 10.91 7.91 38.00 8.88 6.63 34.08
Peers
Company Name CMP
Sun Pharma. Inds. 1844.00
Dr. Reddys Labs. 1212.00
Cipla 1381.00
Lupin 2120.10
Zydus Lifesciences 1161.00
View more..